Genedrive appoints Chris Yates to its Board as Non-Executive Director

– UK, Manchester – genedrive plc (AIM:GDR), the near patient molecular diagnostics company, today announces that it has appointed Chris Yates as Non-Executive Director with immediate effect.

Chris co-founded diagnostics group Abingdon Health in 2008 and, after initially serving as a non-executive director, he has been Abingdon’s CEO since July 2015. Chris has over 20 years’ experience of working in listed company environments. Prior to Abingdon, he was CFO of AIM-listed Immunodiagnostic Systems Holdings PLC and Cozart plc. Chris is a Chartered Accountant and has a degree in economics from the University of Cambridge.

Ian Gilham, Non-Executive Chairman of genedrive, said: “Chris has strong experience in diagnostics businesses as well a deep understanding of the AIM market. We look forward to working with him in the next phase of the Company’s growth.”

Chris Yates said: “I am excited to join the Board at what is a very exciting and critical stage of the growth of the company. The diagnostics market is a large and attractive marketplace and the Company appears well placed to exploit the potential of the Genedrive system.”

About genedrive

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive platform and MTB/RIF assay has been launched in India and a Genedrive HCV test has received CE-IVD Certification and has been launched in Africa. genedrive has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive platform in the EMEA and Asia Pacific regions, and with ARKRAY Healthcare pvt Ltd for the distribution of the Genedrive HCV ID Kit and Genedrive platform in India.

For more information : http://www.genedriveplc.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.